Pharma-FDA collaboration can boost DTC as public health tool

07/15/2013 | Medical Marketing & Media

The FDA can make a difference in direct-to-consumer communications by working with the pharmaceutical industry, writes Peter Pitts, president of the Center for Medicine in the Public Interest and a former associate commissioner at the FDA. Pitts writes about whether spending $10 million on 11 Office of Prescription Drug Promotion research projects is the best way to improve DTC ads. PhRMA assistant general counsel Jeff Francer said "many stakeholders are asking for regulatory guidance."

View Full Article in:

Medical Marketing & Media